查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2018735

心血管針市場：2026-2032年全球市場預測（依產品類型、規格、材質、塗層、最終用戶和應用分類）

Cardiovascular Needle Market by Product Type, Gauge, Material, Coating, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，心血管針頭市場價值將達到 9,556 萬美元，到 2026 年將成長至 1.0205 億美元，到 2032 年將達到 1.5,675 億美元，複合年成長率為 7.32%。

主要市場統計數據
基準年 2025 9556萬美元
預計年份：2026年 1.0205億美元
預測年份 2032 1.5675億美元
複合年成長率 (%) 7.32%

從策略觀點塑造心血管針生態系統的關鍵臨床需求、器材創新方向、監管影響和相關人員需求。

心血管穿刺針市場處於臨床需求、醫療設備創新以及不斷變化的安全性和監管要求的交匯點。近年來，臨床醫生和採購團隊一直在尋求能夠降低手術風險、提高血管通路和心臟介入手術精準度以及改善用戶人體工學以實現可重複操作的醫療設備。因此，製造商正在努力平衡傳統的機械可靠性與諸如安全功能、更精細的規格選擇和先進材料等漸進式創新，以滿足臨床醫生的偏好和患者安全需求。

不斷變化的臨床安全期望、材料創新和程序轉變正在重塑整個心血管針頭市場的產品設計重點和供應商策略。

心血管穿刺針市場正經歷一場變革，其驅動力包括對臨床安全性的更高期望、材料科學的進步以及微創治療方式的普及。隨著醫療系統加強減少針刺傷並遵守職業安全標準，以安全為導向的穿刺針設計日益受到關注。同時，鎳鈦合金等材料的創新正在改善穿刺針的彎曲性能和抗扭轉性能，而矽膠和特殊聚合物等先進塗層則提高了穿刺性能和患者舒適度。

美國近期關稅調整如何促使醫療設備製造商和經銷商迅速重組其供應鏈、轉移區域採購並投資於增強韌性。

關稅政策和貿易調整將對製造商的成本基礎和醫療服務提供者的採購決策產生重大影響，尤其是在零件和成品在生產和分銷過程中跨境運輸的情況下。 2025年，美國實施的新關稅措施將給整個供應鏈帶來壓力，迫使製造商重新評估其籌資策略、庫存佈局和短期定價策略，以維持穩定的利潤率和市場競爭力。

從詳細的細分觀點，將產品變化、臨床應用、材料和塗層選擇與採購趨勢和臨床醫生的決策標準連結起來。

精細化的細分觀點能夠清楚地揭示產品和臨床路徑，從而指導產品組合策略和商業化工作。根據產品類型，心血管穿刺針產品組合包括傳統穿刺針產品（含自動化穿刺平台）、皮下注射和導引器等，以及配備主動和被動安全機制的安全穿刺針解決方案。在確定每種產品的定位時，了解臨床醫生的偏好和特定手術需求至關重要。根據最終用戶，不同門診手術中心、診所和醫院的採購趨勢和設備使用情況各不相同。這些機構在資本投資週期、庫存管理實踐和臨床醫生培訓資源方面存在顯著差異，從而影響部署計劃。

區域市場動態決定了需要製定針對特定區域的商業化策略，以適應世界各地法規、採購行為和製造地的複雜性。

在全球背景下，區域趨勢正以不同的方式影響醫療產品的取得、分銷和定位。在美洲，大規模醫療系統之間的採購整合以及對職業安全的重視，推動了對安全設計醫療器材和簡化合約模式的需求，這些模式支援批量採購和標準化培訓項目。相較之下，歐洲、中東和非洲的監管環境各異，採購機制也存在差異，這要求製造商採取靈活的監管策略和區域性的商業性方法，以滿足分散的市場進入要求。

主要醫療設備製造商之間的競爭地位取決於技術差異化、臨床證據的創造、供應鏈的靈活性以及有針對性的商業化策略。

心血管針頭領域的競爭動態由技術差異化、監管合規性和產品上市能力三者共同決定。主要企業正積極推動內部產品研發和有針對性的夥伴關係，以加速安全功能的整合、材料升級和塗層最佳化，從而提升臨床操作體驗。同時，多家企業正加大對品管和上市後監測能力的投入，以驗證產品在真實臨床環境中的安全性和性能，這為與大型醫療系統和採購集團的合約談判奠定了基礎。

製造商和供應商的具體策略重點，旨在透過產品安全、供應鏈韌性、臨床醫生教育和適應性商業模式來促進產品推廣。

產業領導企業應採取實際措施，使產品開發、供應鏈韌性和銷售活動與臨床醫生和採購部門的需求保持一致。首先，他們應優先投資於以安全為中心的設計和塗層，以顯著減少插入創傷並改善操作，並透過真實世界的臨床評估檢驗這些說法。其次，他們應促進供應商多元化和區域組裝基地的擴張，以降低貿易政策變化帶來的風險，並縮短醫院和門診診所等關鍵客戶的補貨週期。

採用透明的混合方法研究途徑，結合臨床醫生訪談、監管審查和供應鏈分析，為醫療設備策略洞察和建議提供支援。

本研究採用綜合分析方法，結合定性專家訪談、臨床實踐回顧、監管指南分析和供應鏈評估等多方面調查方法，對心血管穿刺針領域進行了深入剖析。主要研究內容包括與介入醫師、採購經理和醫療設備工程師進行結構化討論，以了解實際應用中的偏好、挑戰和推動因素。次要研究內容包括分析法規結構、醫療設備指南和同行評審文獻，以檢驗安全性和性能主題，並將材料和塗層創新置於既定的臨床實踐背景下進行解讀。

策略整合強調需要協調以安全主導的產品創新、證據產生和供應鏈韌性，以滿足不斷變化的臨床和採購需求。

總而言之，心血管針頭市場格局呈現出多方面需求的整合，包括提高安全性、改進材料和塗層，以及增強供應鏈韌性，以應對不斷變化的臨床工作流程和行業趨勢。能夠根據醫院、門診手術中心和診所的細微需求調整產品藍圖的製造商，將更有利於獲得臨床醫生的支持和採購承諾。強調安全特性、加強臨床醫生培訓以及採用在地化供應策略，對於確保產品被廣泛接受和實現永續的市場進入至關重要。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：心血管針市場：依產品類型分類

  • 自動針
  • 普通針頭
  • 安全針

第9章：心血管針頭市場（依規格分類）

  • 厚規格
  • 中型軌距
  • 細規格

第10章 心血管穿刺針市場：依材料分類

  • 鎳鈦
  • 不銹鋼

第11章：心血管針頭市場（依塗層分類）

  • 聚合物
  • 矽酮

第12章 心血管針市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院

第13章 心血管針市場：依應用領域分類

  • 麻醉
  • 心血管外科
  • 藥物輸送
  • 血管通路

第14章 心血管針市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 心血管針市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 心血管針市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 美國心血管針市場

第18章 中國心血管針市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Assut Europe Sarl
  • Aurolab
  • B. Braun Melsungen AG
  • Barrett Surgical Needles
  • DemeTECH Corporation
  • FCI Ophthalmics
  • FSSB Surgical Needles
  • Fumis Medical
  • Johnson & Johnson Services, Inc.
  • KLS Martin Group
  • MANI, Inc.
  • Medtronic plc
  • Medtronic plc
  • Peters Surgical
  • RUMEX International
  • Scanlan International, Inc.
  • Serag-Wiessner GmbH
  • Surgical Specialties Corporation
  • Sutures India Pvt. Ltd.
  • Teleflex Incorporated
  • WL Gore & Associates, Inc.
Product Code: MRR-CA17E905E9F5

The Cardiovascular Needle Market was valued at USD 95.56 million in 2025 and is projected to grow to USD 102.05 million in 2026, with a CAGR of 7.32%, reaching USD 156.75 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 95.56 million
Estimated Year [2026] USD 102.05 million
Forecast Year [2032] USD 156.75 million
CAGR (%) 7.32%

A strategic orientation to the critical clinical needs, device innovation vectors, regulatory influences, and stakeholder imperatives shaping the cardiovascular needle ecosystem

The cardiovascular needle landscape is at the intersection of clinical demand, device innovation, and evolving safety and regulatory expectations. In recent years clinicians and procurement teams have sought devices that reduce procedural risk, enhance precision in vascular access and cardiac interventions, and improve user ergonomics for repeatable performance. As a result, manufacturers are balancing traditional mechanical reliability with incremental innovations such as safety features, refined gauge selection, and advanced materials to address clinician preferences and patient safety needs.

Moving forward, stakeholders must navigate a complex ecosystem that includes supplier consolidation, shifting reimbursement priorities in care settings, and heightened attention to occupational safety. Therefore stakeholders should prioritize an evidence-driven understanding of device performance, real-world usability, and post-market surveillance data. This introduction sets the stage for deeper analysis by framing the core clinical imperatives, technological trajectories, and market dynamics that inform strategic decisions across development, procurement, and clinical adoption pathways.

Evolving clinical safety expectations, material innovations, and procedural migration are reshaping product design priorities and supplier strategies across the cardiovascular needle landscape

The cardiovascular needle market is undergoing transformative shifts driven by clinical safety expectations, material science advances, and procedural migration toward less invasive care pathways. Safety-enabled needle designs are gaining prominence as healthcare systems intensify efforts to reduce needlestick injuries and comply with occupational safety standards. Concurrently, materials innovations such as nickel-titanium alloys are enabling improved flexural properties and kink resistance, while refined coatings like silicone and specialty polymers are enhancing insertion performance and patient comfort.

In parallel, care delivery evolution is reshaping demand patterns: a gradual shift of select procedures from inpatient hospital settings to ambulatory surgery centers and clinic-based environments is incentivizing compact, user-friendly devices that support rapid turnover and lower total procedural cost. These converging dynamics are prompting manufacturers to focus on modular product portfolios, targeted clinician training, and differentiated value propositions that emphasize safety, ease of use, and clinical outcomes. As a result, competitive advantage is increasingly tied to integrated offerings that align device attributes with evolving procedural workflows and procurement priorities.

How recent United States tariff adjustments prompted rapid supply chain recalibration, regional sourcing shifts, and resilience investments across device manufacturers and distributors

Tariff policies and trade adjustments can materially affect the cost base for manufacturers and the procurement calculus for healthcare providers, particularly when components or finished devices cross borders during production and distribution. In 2025, new tariff measures introduced by the United States exerted pressure across supply chains, prompting manufacturers to reassess sourcing strategies, inventory positioning, and near-term pricing approaches to maintain margin stability and market competitiveness.

Consequently, several manufacturers prioritized regional manufacturing realignment and increased use of local suppliers to mitigate exposure to tariff-related cost volatility. At the same time, distributors and large healthcare systems accelerated dialogues with multiple suppliers to secure continuity of supply and negotiate more flexible contract terms. These adaptations drove a renewed focus on supply chain resilience: companies invested in diversified supplier networks, inventory buffering in strategic locations, and more granular cost modeling to pass transparent, defensible pricing to procurement stakeholders while preserving critical device availability for clinical teams.

In-depth segmentation perspective linking product variants, clinical applications, and material and coating choices to procurement dynamics and clinician decision criteria

A granular segmentation lens reveals distinct product and clinical pathways that should guide portfolio strategy and commercialization efforts. Based on product type, cardiovascular needle portfolios span automatic needle platforms, conventional needle offerings that include both hypodermic and introducer variants, and safety needle solutions that encompass active and passive safety mechanisms; understanding clinician preference and procedure-specific requirements is essential when positioning each variant. Based on end user, purchasing dynamics and device utilization differ across ambulatory surgery centers, clinics, and hospitals, where capital procurement cycles, inventory practices, and clinician training resources vary significantly and influence adoption timelines.

Based on application, device design and performance expectations diverge for anesthesia procedures, cardiovascular surgery, drug delivery applications, and vascular access interventions, requiring manufacturers to align features with procedure-specific performance criteria. Based on gauge, clinical selection between large, medium, and small gauges reflects trade-offs in flow characteristics, tissue trauma, and device handling that materially influence clinician choice. Based on material, the selection between nickel titanium and stainless steel impacts mechanical performance, fatigue resistance, and sterilization considerations. Based on coating, uncoated needles and those with polymer or silicone finishes present different insertion profiles and patient comfort attributes. Integrating these segmentation views into R&D, regulatory strategy, and field education programs enables targeted value propositions that address differentiated clinical and procurement needs.

Regional market dynamics demand tailored commercialization strategies that align regulatory complexity, procurement behaviors, and manufacturing footprints across global territories

Regional dynamics shape access, distribution, and product positioning in distinct ways across the global landscape. In the Americas, procurement consolidation among large healthcare systems and a strong emphasis on occupational safety drive demand for safety-engineered devices and simplified contract models that support large-volume purchasing and standardized training programs. In contrast, Europe, Middle East & Africa exhibit diverse regulatory landscapes and heterogeneous procurement mechanisms, prompting manufacturers to adopt flexible regulatory strategies and localized commercial approaches to meet fragmented market access requirements.

The Asia-Pacific region continues to be characterized by rapid adoption of minimally invasive techniques, a growing private healthcare sector, and increasing local manufacturing capabilities that together create both opportunity and competitive pressure for multinational suppliers. These regional contrasts necessitate differentiated go-to-market strategies, including region-specific clinical evidence generation, localized manufacturing or assembly where appropriate, and tailored commercial models that reflect payer structures and procurement norms in each geography.

Competitive positioning driven by engineering differentiation, clinical evidence generation, supply chain agility, and targeted commercialization tactics among leading device manufacturers

Competitive dynamics in the cardiovascular needle arena are shaped by a combination of engineering differentiation, regulatory compliance, and go-to-market execution. Leading players pursue a mix of organic product development and targeted partnerships to accelerate safety feature integration, material upgrades, and coating optimizations that improve clinical handling. At the same time, several firms are investing in quality management and post-market surveillance capabilities to demonstrate real-world safety and performance, which supports contracting conversations with major health systems and procurement groups.

Additionally, strategic distribution partnerships and selective regional manufacturing investments are common tactics to reduce lead times and tariff exposure while enhancing service responsiveness. Companies that succeed tend to combine robust clinical evidence packages with flexible commercial models, clinician education initiatives, and responsive supply chain practices that together create defensible differentiation in both institutional tenders and point-of-care adoption scenarios. For new entrants, focused niche strategies-such as specialized introducer needles or premium-coated drug-delivery variants-can unlock clinical advocacy when paired with targeted outcomes data and practical training support.

Actionable strategic priorities for manufacturers and suppliers to drive adoption through product safety, supply chain resilience, clinician education, and adaptive commercial models

Industry leaders should take pragmatic steps to align product development, supply chain resilience, and commercial outreach with clinician and procurement needs. First, prioritize investment in safety-enabled designs and coatings that demonstrably reduce insertion trauma and improve handling, while concurrently validating those claims through real-world clinical evaluations. Next, pursue supplier diversification and regional assembly footprints to reduce exposure to trade policy shifts and to shorten replenishment cycles for critical hospital and ambulatory customers.

Furthermore, focus commercial efforts on building clinician trust through structured education programs, case-based evidence dissemination, and collaborative pilot initiatives that facilitate early adoption. Align pricing and contracting strategies with the procurement realities of hospitals, ambulatory surgery centers, and clinics by offering flexible purchasing models and clear value justification tied to safety and procedural efficiency. Finally, integrate post-market feedback loops into product roadmaps to continuously refine device ergonomics and performance in response to clinician insights, thereby maintaining a sustainable competitive edge in a rapidly evolving clinical environment.

A transparent mixed-methods research approach integrating clinician interviews, regulatory review, and supply chain analysis to underpin strategic device insights and recommendations

This research synthesis draws on a multi-source methodology that combines qualitative expert interviews, clinical practice reviews, regulatory guidance analysis, and supply chain assessment to generate a robust perspective on the cardiovascular needle domain. Primary inputs included structured discussions with interventional clinicians, procurement leaders, and device engineers to capture real-world preferences, pain points, and adoption drivers. Secondary inputs encompassed analysis of regulatory frameworks, device guidance, and peer-reviewed literature to validate safety and performance themes and to contextualize material and coating innovations within accepted clinical practice.

Analytical steps included cross-referencing clinician-reported needs with product feature sets, mapping procurement behaviors across hospital, ambulatory surgery center, and clinic settings, and evaluating supply chain risk under recent tariff scenarios to assess resilience strategies. Findings were synthesized to highlight actionable implications for product design, market entry, and commercial execution, and to identify areas where further targeted clinical evaluation or pilot deployment would meaningfully reduce adoption friction and support contracting discussions.

Strategic synthesis highlighting the imperative to align safety-driven product innovation, evidence generation, and supply chain resilience to meet evolving clinical and procurement demands

In summary, the cardiovascular needle landscape is defined by converging demands for enhanced safety, material and coating refinement, and supply chain resilience in response to shifting clinical workflows and trade dynamics. Manufacturers that align their product roadmaps with the nuanced needs of hospitals, ambulatory surgery centers, and clinics will be better positioned to secure clinician advocacy and procurement commitments. Emphasizing safety features, clinician training, and localized supply strategies will be critical levers for adoption and sustained market access.

Looking ahead, continued collaboration between manufacturers, clinicians, and procurement teams will accelerate the translation of incremental device improvements into measurable clinical and operational benefits. By maintaining a rigorous focus on evidence generation, flexible commercial approaches, and responsive supply chain design, stakeholders can navigate policy headwinds and evolving care models while delivering devices that meet the highest standards of safety and performance.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cardiovascular Needle Market, by Product Type

  • 8.1. Automatic Needle
  • 8.2. Conventional Needle
  • 8.3. Safety Needle

9. Cardiovascular Needle Market, by Gauge

  • 9.1. Large Gauge
  • 9.2. Medium Gauge
  • 9.3. Small Gauge

10. Cardiovascular Needle Market, by Material

  • 10.1. Nickel Titanium
  • 10.2. Stainless Steel

11. Cardiovascular Needle Market, by Coating

  • 11.1. Polymer
  • 11.2. Silicone

12. Cardiovascular Needle Market, by End User

  • 12.1. Ambulatory Surgery Center
  • 12.2. Clinics
  • 12.3. Hospitals

13. Cardiovascular Needle Market, by Application

  • 13.1. Anesthesia
  • 13.2. Cardiovascular Surgery
  • 13.3. Drug Delivery
  • 13.4. Vascular Access

14. Cardiovascular Needle Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Cardiovascular Needle Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Cardiovascular Needle Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Cardiovascular Needle Market

18. China Cardiovascular Needle Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Assut Europe Sarl
  • 19.6. Aurolab
  • 19.7. B. Braun Melsungen AG
  • 19.8. Barrett Surgical Needles
  • 19.9. DemeTECH Corporation
  • 19.10. FCI Ophthalmics
  • 19.11. FSSB Surgical Needles
  • 19.12. Fumis Medical
  • 19.13. Johnson & Johnson Services, Inc.
  • 19.14. KLS Martin Group
  • 19.15. MANI, Inc.
  • 19.16. Medtronic plc
  • 19.17. Medtronic plc
  • 19.18. Peters Surgical
  • 19.19. RUMEX International
  • 19.20. Scanlan International, Inc.
  • 19.21. Serag-Wiessner GmbH
  • 19.22. Surgical Specialties Corporation
  • 19.23. Sutures India Pvt. Ltd.
  • 19.24. Teleflex Incorporated
  • 19.25. W.L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CARDIOVASCULAR NEEDLE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CARDIOVASCULAR NEEDLE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY GAUGE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY COATING, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES CARDIOVASCULAR NEEDLE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA CARDIOVASCULAR NEEDLE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY AUTOMATIC NEEDLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY AUTOMATIC NEEDLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY AUTOMATIC NEEDLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY CONVENTIONAL NEEDLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY CONVENTIONAL NEEDLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY CONVENTIONAL NEEDLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY SAFETY NEEDLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY SAFETY NEEDLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY SAFETY NEEDLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY LARGE GAUGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY LARGE GAUGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY LARGE GAUGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY MEDIUM GAUGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY MEDIUM GAUGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY MEDIUM GAUGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY SMALL GAUGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY SMALL GAUGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY SMALL GAUGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY NICKEL TITANIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY NICKEL TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY NICKEL TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY POLYMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY POLYMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY POLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY ANESTHESIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY ANESTHESIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY ANESTHESIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY VASCULAR ACCESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY VASCULAR ACCESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY VASCULAR ACCESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS CARDIOVASCULAR NEEDLE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS CARDIOVASCULAR NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS CARDIOVASCULAR NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS CARDIOVASCULAR NEEDLE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS CARDIOVASCULAR NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE CARDIOVASCULAR NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE CARDIOVASCULAR NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE CARDIOVASCULAR NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE CARDIOVASCULAR NEEDLE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE CARDIOVASCULAR NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. MIDDLE EAST CARDIOVASCULAR NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. MIDDLE EAST CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. MIDDLE EAST CARDIOVASCULAR NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST CARDIOVASCULAR NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST CARDIOVASCULAR NEEDLE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST CARDIOVASCULAR NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. AFRICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. AFRICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. AFRICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC CARDIOVASCULAR NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC CARDIOVASCULAR NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC CARDIOVASCULAR NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC CARDIOVASCULAR NEEDLE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC CARDIOVASCULAR NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. ASEAN CARDIOVASCULAR NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. ASEAN CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. ASEAN CARDIOVASCULAR NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN CARDIOVASCULAR NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN CARDIOVASCULAR NEEDLE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN CARDIOVASCULAR NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. GCC CARDIOVASCULAR NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GCC CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. GCC CARDIOVASCULAR NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 127. GCC CARDIOVASCULAR NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 128. GCC CARDIOVASCULAR NEEDLE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 129. GCC CARDIOVASCULAR NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. GCC CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPEAN UNION CARDIOVASCULAR NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPEAN UNION CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPEAN UNION CARDIOVASCULAR NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION CARDIOVASCULAR NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPEAN UNION CARDIOVASCULAR NEEDLE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION CARDIOVASCULAR NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS CARDIOVASCULAR NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. BRICS CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. BRICS CARDIOVASCULAR NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS CARDIOVASCULAR NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS CARDIOVASCULAR NEEDLE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 143. BRICS CARDIOVASCULAR NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. G7 CARDIOVASCULAR NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. G7 CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. G7 CARDIOVASCULAR NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 148. G7 CARDIOVASCULAR NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 149. G7 CARDIOVASCULAR NEEDLE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 150. G7 CARDIOVASCULAR NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. G7 CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. NATO CARDIOVASCULAR NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. NATO CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. NATO CARDIOVASCULAR NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 155. NATO CARDIOVASCULAR NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 156. NATO CARDIOVASCULAR NEEDLE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 157. NATO CARDIOVASCULAR NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. NATO CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. UNITED STATES CARDIOVASCULAR NEEDLE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 161. UNITED STATES CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. UNITED STATES CARDIOVASCULAR NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED STATES CARDIOVASCULAR NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 164. UNITED STATES CARDIOVASCULAR NEEDLE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 165. UNITED STATES CARDIOVASCULAR NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. CHINA CARDIOVASCULAR NEEDLE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 168. CHINA CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. CHINA CARDIOVASCULAR NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 170. CHINA CARDIOVASCULAR NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 171. CHINA CARDIOVASCULAR NEEDLE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 172. CHINA CARDIOVASCULAR NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)